The CX 3 C chemokine family comprises only one member, CX 3 CL1, also known as fractalkine, which in mice is the sole ligand of the G protein-coupled, 
Introduction
Chemokine (C-X3-C motif) ligand 1 (CX 3 CL1), also known as fractalkine or neurotactin 1, 2 and its receptor CX 3 CR1 3 have been assigned their own CX 3 C chemokine family. This classification is based on the three amino acid gap between its N-terminal cysteines in CX 3 CL1, with no spacing in CC chemokines and only one intervening amino acid in CXC chemokines 4 . CX 3 CL1 is furthermore structurally unique in that it is synthesized as a type I transmembrane protein with the CX 3 C chemokine domain presented on an extended stalk 1, 2 . Both CX 3 CL1 and CX 3 CR1
are widely expressed throughout the organism, but in given tissues expression is often highly cell type-specific. Taking advantage of mice that harbor a targeted replacement of the CX 3 CR1 by a GFP reporter 5 , we could for instance show that CX 3 CR1 expression in the brain is restricted to microglia. CX 3 CR1 expression in the gut was found limited to lamina propria macrophages and CX 3 CR1 expression in the blood is largely restricted to monocytes, which are uniform CX 3 CR1 positive, albeit with discrete expression levels 6 . CX 3 CR1 is furthermore expressed by macrophage/dendritic cell precursors (MDPs) 7 , various DC progenitors, a nonclassical CD8α + DC subset 8 and plasmacytoid DCs. Aside from the prominent expression in the mononuclear myeloid compartment, CX 3 CR1 receptor expression has been reported for an NK cell subset 3, 9 and certain T cell populations 3, 10, 11 . The in vivo expression pattern of the ligand CX 3 CL1 remains less well defined and controversial 12 , but has been reported for neurons 13 , intestinal epithelium 14 and inflamed endothelium 2 . Notably, in humans eotaxin-3/CC chemokine ligand 26 was recently reported to be a functional ligand for CX 3 CR1 15 ; in mice the CCL26 gene is however a pseudogene.
The analysis of CX 3 C receptor and ligand knock-out mice 5, 16 has revealed a number of phenotypes resulting from the lack of CX 3 CR1/CX 3 CL1 interactions [17] [18] [19] [20] .
In depth knowledge of the physiological role of the CX 3 C axis including mechanistic insights is however missing. A key to understanding the biological function of the CX 3 C chemokine family likely lies in the unique structure of the ligand CX 3 CL1.
Whereas classical small peptide chemokines are secreted and form gradients by binding to ECM proteoglycans 21 , CX 3 CL1 is synthesized as a transmembrane protein with the CX 3 C chemokine domain presented on an extended highly glycosylated mucin-like stalk 1, 2 . To date, CX 3 CL1 shares this unique membrane anchorage only with one other chemokine, the CXCR6 ligand CXCL16 22 .
For personal use only. on . by guest www.bloodjournal.org From 4 Expression of the CX 3 C transmembrane chemokine on endothelial and epithelial cells was shown to mediate tight, pertussis toxin-resistant and integrin-independent interactions with CX 3 CR1-expressing leukocytes 23, 24 . Moreover, the adhesive interactions of CX 3 CR1 and CX 3 CL1 were found to be sufficient to support the recruitment of leukocytes through the endothelium of inflamed vasculature 25 .
Proteolytic cleavage by the disintegrin like metalloproteinase ADAM10 results in constitutive release of different sized soluble CX 3 CL1 entities 26 . Moreover, under inflammatory conditions, CX 3 CL1 shedding is also promoted by ADAM17/TACE 27, 28 .
Cleavage could be required for the detachment of cells tethered by the CX 3 CL1/ CX 3 CR1 bond. Furthermore, ecto-domain shedding of CX 3 CL1 generates a potential chemoattractant that could also actively interfere with additional CX 3 CL1/ CX 3 CR1
interactions. Specific contributions of the membrane-tethered vs. shed CX 3 CL1
isoforms to the known in vivo activities of the CX 3 C chemokine family remain however to be established. including the murine CX 3 CL1 locus was modified as described previously using the pDelsac shuttle vector strategy 29 or using REDET recombineering 30 . The were passed through a 100 mm mesh and centrifuged at 1400rpm for 5min at 4℃.
For the flow cytometry analysis, cells were suspended with PBS supplemented with 2mM EDTA, 0.05% sodium azide and 1% of fetal calf serum.
To obtain intestinal epithelial cells and lamina propria cells, large intestine was longitudinally sectioned and cut into small pieces. Colonic epithelial cells were isolated by incubation in 5ml HBSS containing 10mM HEPES and 5mM EDTA (pH 8.0) at 37℃ on a shaking incubator (300rpm) and collected by passing through a 100 mm mesh. For the isolation of lamina propria cells, remnant colon pieces were digested by 5ml HBSS containing 10% FBS, 1mg/ml of dispase II (Roche) and 0.5mg/ml of collagenase D (Sigma) at 37℃ shaking incubator (300 rpm) for 1h. (Jackson laboratory). Brain sections were stained with anti-NeuroN (NeuN) or anti-DCX followed by Cy5 conjugated anti-rabbit Ab or efluor488 conjugated antirabbit Ab. Spinal cord was fixed with 2.5% fresh PFA at 4℃ for 2 days and decalcified by 12.5% EDTA (pH7.4) at 4℃ for 2-3 days. Spinal cord was incubated in 30% sucrose for 2-3 days and lumbar regions (L3-L5) were embedded in OCT.
Frozen L3-L5 was sectioned into 10 mm sections using a sliding microtome.
Sections were stained with biotin anti-CGRP, followed by streptavidin (SA) conjugated aminomethyl coumarin acetate (AMCA). Sections of kidney, lung and brain were imaged from LSM 510 confocal microscopy (Carl Zeiss) equipped with serial tile scanning. Image acquisition was processed with LSM software and Photoshop. Naïve tissue of terminal ileum and intestinal swiss roll sections were also analyzed with LSM 510 confocal microscopy. Spinal cord pictures were taken using a fluorescent microscope.
Two-photon microscopy and surgical procedure. Before imaging, mice were anesthetized by i.p injection of 100 mg ketamine, 15 mg xylazine and 2.5 mg acepromazine per kilogram. After a midway section through the abdominal wall and peritoneum, the ileum was externalized carefully and immobilized using a custombuilt imaging chamber. The lumen was exposed using a cautery (AARON Medical) and carefully flushed with PBS to remove fecal material. During imaging, mice were supplied with oxygen and their core temperature was maintained at 37ºC with a warming plate. Imaging was performed using the Ultima® two-photon microscope fitted with a Ti-sapphire Deep-sea Mai Tai® pulsed laser with a water immersed 20x objective, the excitation wavelength was set to 970 nm. 
ELISA.
For the specific detection of transgene-encoded CX 3 CL1, it was captured from the serum by rat anti-mouse CX 3 CL1 (4ug/ml, R&D systems). As a secondary antibody, we used biotinylated chicken anti-cMyc (1:5000, Immunology Consultant Laboratories Inc.) and streptavidin-HRP. IL-6 and endogenous and transgeneencoded CX 3 CL1 from the serum were measured by ELISA kit (DuoSet ELISA kit, R&D systems) following the manufacturer's protocol.
Assessment of TED formation. Indicated mice were challenged by oral gavage with Aspergillus conidia (300μl of 1-2x 10 8 conidia/ml) 48 .
The following day the mice were sacrificed and analyzed by microscopic analysis for the presence of TEDs.
Only TEDs that reached the lumen were considered for the quantification. Analysis of CX 3 CL1 expression has so far, however, been restricted to in situ hybridization and immunohistochemistry 13, 34, 35 , which provide limited resolution and preclude the analysis of live tissue. To map the distribution of CX 3 CL1 expressing cells in tissue context, we hence adopted a reporter gene approach we had previously applied to the CX 3 CR1 receptor 5 . Specifically, we used homologous recombination to replace the first exon of the CX 3 CL1 gene in a bacterial artificial chromosome (BAC) spanning the CX 3 CL1 locus (RP24-147I16) with a cherry (Figure 1 B-D) but not in the DCX + neuronal precursors (Figure 1 E) . In steady state CX 3 CL1
DSS-induced colitis model and
expression was absent from the brain stem, midbrain and cerebellum (Suppl. In the lung, CX 3 CL1 was found expressed on both alveolar and bronchial epithelial cells including CCSP + Clara cells (Figure 2 A, B) . In the intestinal lamina propria CX 3 CR1 is known to be prominently expressed by a monocyte-derived macrophage population 20, 38 . Intestinal CX 3 CL1 expression on the other hand was reported for the epithelial cell layer and resistant PCR products (Suppl. Figure 5B) . (Fig 6 D) , albeit at slightly reduced numbers (Fig 6 F) , thus validating our approach. More importantly however, TEDs were also readily observed in
:CX 3 CL1 -/-] chimeras (Fig 6 E, F) , establishing that epithelial expression of a secreted CX 3 CL1 entity was sufficient to allow lamina propria CX 3 CR1-expressing macrophages to extend protrusions towards the lumen.
Collectively these results establish that TED formation can be promoted by a secreted, potentially diffusible CX 3 CL1 entity lacking the glycosylated stalk and is hence independent of signaling by the trans-membrane CX 3 CL1 ligand towards the intestinal epithelial cells. 
Restoration of trans-epithelial dendrites affects the robustness of CX 3 CL1-deficient mice to withstand a colitis challenge

Discussion
Here we used a BAC transgenesis approach to study the in vivo expression pattern and structure/function aspects of the unique CX 3 C chemokine CX 3 CL1, known as fractalkine. Specifically, we generated reporter animals that harbor genes encoding red and green fluorescent reporter proteins under the control of the 
CX 3 CR1 and CX 3 CL1 expression are confined to hematopoetic and nonhematopoetic compartments, respectively.
In the healthy brain, CX 3 CL1 expression was found in hippocampal neuronal somata, as well as neurons in the striatum and specific cortical layers. [54] [55] [56] . Furthermore, CX 3 CR1 deficiency was reported to cause microglial neurotoxicity 57 and to promote tau-associated neurodegenerative diseases (tauopathies) 58 . CX 3 CR1-deficient mice seem also less sensitive to neuropathic pain 59 . Supporting a role of the CX 3 C axis in pain sensation we found CX 3 CL1/Cherry expressed by dorsal horn inter-neurons. However, in contrast to a previous report 60 , CX 3 CL1 expression was in steady state absent from the DRG sensory neurons that project CGRP fibers to these inter-neurons. In the healthy lung we found CX 3 CL1 expressed by bronchial and alveolar epithelial cells, while CX 3 CR1 expression was confined to resident lung myeloid cells.
In humans, CX 3 CL1 was reported to be induced on bronchial epithelial cells and smooth muscle cells by inflammatory cytokines 61 . CX 3 CR1 is expressed by alveolar DCs that arise under inflammatory conditions from blood monocytes 62 . Furthermore, CX 3 CR1 expression and curiously also CX 3 CL1 expression can reportedly be [26] [27] [28] . To probe for distinct functions of these membrane-tethered and soluble CX 3 CL1 entities we generated BAC transgenic mice expressing a wt or an obligatory secreted chemokine variant and introduced them onto a CX 3 CL1-deficient genetic background 16 . We then asked whether these transgenes would be able to reconstitute known deficiencies caused by the absence of CX 3 CL1/R1 interactions.
We had previously shown that human and mouse monocytes depend on CX 3 CR1 engagement as a survival signal 41 . In that study recombinant soluble TEDs is under debate and, specifically, it remains to be shown how they are related to reported gut-related phenotypes of CX 3 CR1 KO mice [49] [50] [51] 69 . Interestingly, we establish that TEDs -most likely by allowing CX 3 CR1 + macrophages to sense the gut lumen -can contribute to the robustness of gut homeostasis towards a colitis challenge.
By demonstrating that distinct activities of the CX 3 C axis, such as the promotion of TED formation and monocyte survival depend on the presence of shed and membrane-anchored CX 3 CL1 entities, respectively, we establish for the first time unique in vivo activities of the structurally discrete CX 3 CL1 isoforms. Notably, the anchorage of the CX 3 C domain might be particular critical in the circulation, where shed moieties would be expected to be rapidly diluted and might hence not reach critical local concentrations. In the tissue context, however, the soluble CX 3 C entity might be able to build the required local gradient and hence suffice.
Collectively, the accumulating evidence from our study and the literature suggests CX 3 CR1/L1 interactions as critical component in the development of inflammatory diseases in diverse organs, including the lung, intestine and kidney, as well as neurodegenerative diseases. Although much remains to be elucidated, the CX 3 C family remains an interesting therapeutic target and the future study on molecular mechanism of the CX 3 C axis might well provide new avenues for the treatment of inflammatory diseases.
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